Pharma Earnings Calls Reveal US/EU Trump Divide
Executive Summary
Less than a month after his inauguration, President Donald Trump has both unnerved and empowered industry sectors with his immediate actions or divulged potential reforms. Execs offered measured reaction and some speculation during recent earnings calls.